IL1B and neoplasm: Inflammasome activation in liver cells, including hepatocytes, hepatic stellate cells, and immune cells, can lead to the release of pro-inflammatory cytokines, such as IL-1β and IL-18 [12,13,14,15], which can promote inflammation and contribute to cancer promotion in the tumor microenvironment [16].